Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Sponsor: Huons Co., Ltd.
Summary
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Official title: A Multicenter, Randomized, Single-blind, Active Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
206
Start Date
2026-01
Completion Date
2027-12
Last Updated
2026-01-13
Healthy Volunteers
No
Interventions
HUC3-637
Ophthalmic solution instilled directly into the eye (topical ocular administration)
HUC3-637-R
Ophthalmic solution instilled directly into the eye (topical ocular administration)
Locations (1)
Kangbuk Samsung Hospital
Seoul, South Korea